Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Devonian Health Group Inc. (“Devonian” or the “Company”) (TSXV: GSD; OTCQB: DVHGF), a clinical stage corporation focused on developing unique solution ...

The Secondary Suite Incentive Program supports safe housing for all. The incentive program will provide qualifying homeowners with up to $10,000 to build and register a secondary suite. The incentive ...

Scientists at Michigan Medicine have made a significant breakthrough in treating nonalcoholic fatty liver disease (NAFLD), a ...

If you have obesity, losing even a little weight helps not only improve your overall health, but also prevent liver issues ...

Our success reflects exceptional execution and the urgent need for treatments for this serious liver disease ... the MAESTRO-NASH OUTCOMES trial in compensated cirrhosis could unlock further ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Previous reviews have not comprehensively evaluated and validated these methods, particularly in the context of liver cirrhosis secondary to NAFLD. This review aims to fill this gap by systematically ...

Nonalcoholic steatohepatitis (NASH) is a common disease that may progress to cirrhosis and liver failure. NASH is associated with overnutrition, obesity and insulin resistance. Genetic ...

Figure 1. Common factors contributing to liver injury and their consequences: autoimmune diseases, viral hepatitis, alcohol, drugs, and trauma can cause cirrhosis, hepatocellular carcinoma, and acute ...